Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals Cash on Hand 2011-2025 | AVDL

Avadel Pharmaceuticals cash on hand from 2011 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Avadel Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $74
2023 $105
2022 $96
2021 $157
2020 $221
2019 $64
2018 $100
2017 $94
2016 $154
2015 $145
2014 $93
2013 $7
2012 $9
2011 $24
2010 $31
Avadel Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-06-30 $82
2025-03-31 $66
2024-12-31 $74
2024-09-30 $66
2024-06-30 $71
2024-03-31 $89
2023-12-31 $105
2023-09-30 $153
2023-06-30 $161
2023-03-31 $101
2022-12-31 $96
2022-09-30 $106
2022-06-30 $104
2022-03-31 $123
2021-12-31 $157
2021-09-30 $181
2021-06-30 $203
2021-03-31 $205
2020-12-31 $221
2020-09-30 $232
2020-06-30 $239
2020-03-31 $113
2019-12-31 $64
2019-09-30 $72
2019-06-30 $79
2019-03-31 $80
2018-12-31 $100
2018-09-30 $125
2018-06-30 $147
2018-03-31 $198
2017-12-31 $94
2017-09-30 $116
2017-06-30 $174
2017-03-31 $179
2016-12-31 $154
2016-09-30 $150
2016-06-30 $155
2016-03-31 $160
2015-12-31 $145
2015-09-30
2015-06-30 $116
2015-03-31 $113
2014-12-31 $93
2014-09-30 $76
2014-06-30 $78
2014-03-31 $84
2013-12-31 $7
2013-09-30 $9
2013-06-30 $10
2013-03-31 $15
2012-12-31 $9
2012-09-30
2012-06-30 $20
2012-03-31 $23
2011-12-31 $24
2011-09-30 $29
2011-06-30 $33
2011-03-31 $26
2010-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.859B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.859B 31.85
Zoetis (ZTS) United States $53.434B 19.12
Takeda Pharmaceutical (TAK) Japan $44.834B 9.15
Daiichi Sankyo, - (DSNKY) Japan $42.623B 21.23
BeOne Medicines - (ONC) Switzerland $41.395B 219.46
Sandoz Group AG (SDZNY) Switzerland $30.417B 0.00
United Therapeutics (UTHR) United States $19.872B 17.49
Merck (MKKGY) Germany $17.383B 11.30
Shionogi (SGIOY) Japan $14.751B 13.55
Neurocrine Biosciences (NBIX) United States $14.642B 35.13
Summit Therapeutics (SMMT) United States $14.521B 0.00
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.013B 0.00
Ionis Pharmaceuticals (IONS) United States $11.771B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.295B 0.00
Corcept Therapeutics (CORT) United States $8.246B 89.08
Stevanato Group S.p.A (STVN) Italy $7.171B 40.14
Grifols, S.A (GRFS) Spain $5.975B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.315B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.063B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.738B 17.76
Centessa Pharmaceuticals (CNTA) United Kingdom $3.575B 0.00
Hypermarcas (HYPMY) Brazil $3.161B 21.70
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.800B 8.93
Dyne Therapeutics (DYN) United States $2.658B 0.00
Soleno Therapeutics (SLNO) United States $2.564B 0.00
Ocular Therapeutix (OCUL) United States $2.448B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.049B 24.28
Guardian Pharmacy Services (GRDN) United States $1.998B 38.48
BioCryst Pharmaceuticals (BCRX) United States $1.512B 89.75
Collegium Pharmaceutical (COLL) United States $1.497B 7.41
Ardelyx (ARDX) United States $1.468B 0.00
Harrow (HROW) United States $1.424B 87.36
Amylyx Pharmaceuticals (AMLX) United States $1.354B 0.00
Xeris Biopharma Holdings (XERS) United States $1.259B 0.00
Enliven Therapeutics (ELVN) United States $1.202B 0.00
Oruka Therapeutics (ORKA) United States $1.176B 0.00
Nektar Therapeutics (NKTR) United States $1.173B 0.00
Evotec AG (EVO) Germany $1.115B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Xencor (XNCR) United States $1.028B 0.00
Cronos Group (CRON) Canada $0.973B 0.00
Theravance Biopharma (TBPH) United States $0.895B 37.83
ARS Pharmaceuticals (SPRY) United States $0.884B 0.00
Organogenesis (ORGO) United States $0.822B 0.00
ProKidney (PROK) United States $0.789B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.725B 6.47
Esperion Therapeutics (ESPR) United States $0.724B 0.00
Elite Pharmaceuticals (ELTP) United States $0.717B 0.00
Savara (SVRA) United States $0.712B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Bioventus (BVS) United States $0.632B 12.97
4D Molecular Therapeutics (FDMT) United States $0.627B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.505B 11.96
Lexeo Therapeutics (LXEO) United States $0.497B 0.00
Akebia Therapeutics (AKBA) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.445B 6.09
Altimmune (ALT) United States $0.441B 0.00
Galectin Therapeutics (GALT) United States $0.376B 0.00
Nature's Sunshine Products (NATR) United States $0.362B 21.55
USANA Health Sciences (USNA) United States $0.354B 9.89
Lyell Immunopharma (LYEL) United States $0.339B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Korro Bio (KRRO) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.279B 0.00
Pyxis Oncology (PYXS) United States $0.272B 0.00
Aclaris Therapeutics (ACRS) United States $0.261B 0.00
Achieve Life Sciences (ACHV) Canada $0.251B 0.00
Journey Medical (DERM) United States $0.239B 0.00
AleAnna (ANNA) United States $0.230B 0.00
OmniAb (OABI) United States $0.226B 0.00
Protara Therapeutics (TARA) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Cassava Sciences (SAVA) United States $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.155B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.137B 0.00
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Incannex Healthcare (IXHL) Australia $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.115B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.108B 0.00
Gain Therapeutics (GANX) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.095B 34.35
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.083B 0.00
Prelude Therapeutics (PRLD) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Talphera (TLPH) United States $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.75
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00